Browsing Tag
Ambition 2030
3 posts
Munich Re (ETR: MUV2) trades 23% below 52-week high as reinsurance pricing softens into hurricane season
Munich Re beat Q1 by 57% and reaffirmed €6.3bn guidance. The stock is down 23%. The real question is whether softening renewal prices break the Ambition 2030 thesis.
Sabre Insurance (LON: SBRE) posts 4.9% profit rise and £5m buyback despite premium retreat in 2025
Sabre Insurance (SBRE) grew profit before tax 4.9% to £51m in 2025, lifted its dividend to 13.5p and launched a £5m buyback. Find out what it means for investors.
AstraZeneca to bolster US footprint with multi-billion dollar strategy
In a bold move set to reshape the pharmaceutical landscape, AstraZeneca has announced a substantial $3.5 billion investment…